Disposition of 1796 shares by Christian Klemt of Uniqure NV at 7.55 subject to Rule 16b-3

QURE Stock  USD 15.49  0.43  2.86%   
About 58% of all Uniqure NV's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Uniqure NV suggests that some traders are interested. The current market sentiment, together with Uniqure NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Uniqure NV stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Uniqure NV Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at news.google.com
Google News at Macroaxis
  
Disposition of 1796 ordinary shares at 7.55 of Uniqure NV by Christian Klemt on 9th of December 2024. This event was filed by Uniqure NV with SEC on 2024-12-09. Statement of changes in beneficial ownership - SEC Form 4

Uniqure NV Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Uniqure NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Uniqure NV Fundamental Analysis

We analyze Uniqure NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Uniqure NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Uniqure NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Uniqure NV is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Uniqure NV Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Uniqure NV stock to make a market-neutral strategy. Peer analysis of Uniqure NV could also be used in its relative valuation, which is a method of valuing Uniqure NV by comparing valuation metrics with similar companies.

Peers

Uniqure NV Related Equities

XFORX4 Pharmaceuticals   16.58   
0%
100.0%
SLDBSolid Biosciences   5.56   
0%
33.0%
MRUSMerus BV   2.39   
0%
14.0%
TERNTerns Pharmaceuticals   1.67   
0%
10.0%
MGTXMeiraGTx Holdings   1.66   
0%
10.0%
PTGXProtagonist Therapeutics   1.51   
0%
9.0%
REPLReplimune   1.15   
0%
6.0%
INZYInozyme Pharma   0.67   
0%
4.0%
KNSAKiniksa Pharmaceuticals   0.1   
0%
1.0%
AMLXAmylyx Pharmaceuticals   0.00   
0%
0%
LRMRLarimar Therapeutics   0.33   
1.0%
0%
PHATPhathom Pharmaceuticals   0.38   
2.0%
0%
GPCRStructure Therapeutics   0.63   
3.0%
0%
RYTMRhythm Pharmaceuticals   0.79   
4.0%
0%
SNDXSyndax Pharmaceuticals   1.11   
6.0%
0%
DAWNDay One   2.89   
17.0%
0%
STROSutro Biopharma   3.18   
19.0%
0%
RNAAvidity Biosciences   3.97   
23.0%
0%
PCVXVaxcyte   3.99   
24.0%
0%
RGNXRegenxbio   4.13   
24.0%
0%
RCKTRocket Pharmaceuticals   5.65   
34.0%
0%
ABOSAcumen Pharmaceuticals   7.34   
44.0%
0%

Complementary Tools for Uniqure Stock analysis

When running Uniqure NV's price analysis, check to measure Uniqure NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Uniqure NV is operating at the current time. Most of Uniqure NV's value examination focuses on studying past and present price action to predict the probability of Uniqure NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Uniqure NV's price. Additionally, you may evaluate how the addition of Uniqure NV to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets